Ke Gu

Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo

Yu Wen, Ke Gu, Zhan Yu et al. · Cancer Letters · 2012 · 73 citations

Medicine, Oncology, Pharmacology +14

TAZ promotes the proliferation and osteogenic differentiation of human periodontal ligament stem cells via the p‐SMAD3

Ke Gu, Xucheng Fu, Hui Tian et al. · Journal of Cellular Biochemistry · 2019 · 40 citations

Life Sciences, Cell Biology, Molecular Biology +17

Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study

Jian-Dong Zhao, Jin Liu, Zhi-Gang Ren et al. · Radiation Oncology · 2010 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway

Aonan Li, Ke Gu, Qi Wang et al. · International Journal of Molecular Medicine · 2018 · 35 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK

Yang Gao, Hua-Xing Li, Li-Tao Xu et al. · Molecular Biology Reports · 2011 · 33 citations

Medicine, Oncology, Pharmacology +14